828 related articles for article (PubMed ID: 9278309)
21. The membrane immunoglobulin receptor utilizes a Shc/Grb2/hSOS complex for activation of the mitogen-activated protein kinase cascade in a B-cell line.
Kumar G; Wang S; Gupta S; Nel A
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):215-23. PubMed ID: 7717978
[TBL] [Abstract][Full Text] [Related]
22. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
[TBL] [Abstract][Full Text] [Related]
24. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
Pan J; Fukuda K; Saito M; Matsuzaki J; Kodama H; Sano M; Takahashi T; Kato T; Ogawa S
Circ Res; 1999 May; 84(10):1127-36. PubMed ID: 10347087
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
26. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
[TBL] [Abstract][Full Text] [Related]
27. Downstream effectors of oncogenic ras in multiple myeloma cells.
Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy.
Pearson MA; O'Farrell AM; Dexter TM; Whetton AD; Owen-Lynch PJ; Heyworth CM
Growth Factors; 1998; 15(4):293-306. PubMed ID: 9714913
[TBL] [Abstract][Full Text] [Related]
29. Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3.
Zauberman A; Zipori D; Krupsky M; Ben-Levy R
Oncogene; 1999 Jul; 18(26):3886-93. PubMed ID: 10445852
[TBL] [Abstract][Full Text] [Related]
30. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway.
Stancato LF; Sakatsume M; David M; Dent P; Dong F; Petricoin EF; Krolewski JJ; Silvennoinen O; Saharinen P; Pierce J; Marshall CJ; Sturgill T; Finbloom DS; Larner AC
Mol Cell Biol; 1997 Jul; 17(7):3833-40. PubMed ID: 9199317
[TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
Kim H; Hawley TS; Hawley RG; Baumann H
Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.
Neumann C; Zehentmaier G; Danhauser-Riedl S; Emmerich B; Hallek M
Eur J Immunol; 1996 Feb; 26(2):379-84. PubMed ID: 8617307
[TBL] [Abstract][Full Text] [Related]
33. Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells.
Berger LC; Hawley RG
Blood; 1997 Jan; 89(1):261-71. PubMed ID: 8978300
[TBL] [Abstract][Full Text] [Related]
34. Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma.
Burger R; Guenther A; Bakker F; Schmalzing M; Bernand S; Baum W; Duerr B; Hocke GM; Steininger H; Gebhart E; Gramatzki M
Hematol J; 2001; 2(1):42-53. PubMed ID: 11920233
[TBL] [Abstract][Full Text] [Related]
35. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
Gollob JA; Schnipper CP; Murphy EA; Ritz J; Frank DA
J Immunol; 1999 Apr; 162(8):4472-81. PubMed ID: 10201984
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
[TBL] [Abstract][Full Text] [Related]
37. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
[TBL] [Abstract][Full Text] [Related]
38. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
Purkerson JM; Parker DC
J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
[TBL] [Abstract][Full Text] [Related]
39. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
40. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
